Veracyte Inc. (NASDAQ: VCYT) on June 22, 2022, started off the session at the price of $17.08, soaring 7.21% from the previous trading day. During the day, the shares moved up to $18.975 and dropped to $17.00 before settling in for the closing price of $17.48. Within the past 52 weeks, VCYT’s price has moved between $14.85 and $54.13.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Annual sales at Healthcare sector company grew by 27.50% over the past five years. The company achieved an average annual earnings per share of -69.70%. With a float of $70.86 million, this company’s outstanding shares have now reached $71.23 million.
Let’s look at the performance matrix of the company that is accounted for 761 employees. In terms of profitability, gross margin is +57.84, operating margin of -26.87, and the pretax margin is -37.20.
Veracyte Inc. (VCYT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The most recent insider transaction that took place on Jun 14, was worth 141,846. In this transaction Director of this company sold 8,720 shares at a rate of $16.27, taking the stock ownership to the 2,000 shares. Before that another transaction happened on Jun 10, when Company’s Chief Executive Officer bought 60,000 for $16.33, making the entire transaction worth $980,094. This insider now owns 159,761 shares in total.
Veracyte Inc. (VCYT) Performance Highlights and Predictions
As on 3/30/2022, Multinational firm has announced its last quarter scores, in which it reported -$0.2 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.24) by $0.04. This company achieved a net margin of -34.42 while generating a return on equity of -9.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -69.70% per share during the next fiscal year.
Veracyte Inc. (NASDAQ: VCYT) Trading Performance Indicators
Veracyte Inc. (VCYT) is currently performing well based on its current performance indicators. A quick ratio of 3.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.69, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Veracyte Inc. (VCYT)
Veracyte Inc. (NASDAQ: VCYT) saw its 5-day average volume 1.39 million, a positive change from its year-to-date volume of 0.94 million. As of the previous 9 days, the stock’s Stochastic %D was 64.60%. Additionally, its Average True Range was 1.49.
During the past 100 days, Veracyte Inc.’s (VCYT) raw stochastic average was set at 21.16%, which indicates a significant decrease from 93.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.75% in the past 14 days, which was lower than the 88.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.25, while its 200-day Moving Average is $33.01. Nevertheless, the first resistance level for the watch stands at $19.48 in the near term. At $20.21, the stock is likely to face the second major resistance level. The third major resistance level sits at $21.45. If the price goes on to break the first support level at $17.50, it is likely to go to the next support level at $16.26. Assuming the price breaks the second support level, the third support level stands at $15.53.
Veracyte Inc. (NASDAQ: VCYT) Key Stats
Market capitalization of the company is 1.34 billion based on 71,445K outstanding shares. Right now, sales total 219,510 K and income totals -75,560 K. The company made 67,780 K in profit during its latest quarter, and -14,460 K in sales during its previous quarter.